Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- PMID: 14711538
- DOI: 10.1016/j.fertnstert.2003.10.004
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
Abstract
Since the 1990 National Institutes of Health-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome, and as such no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.
Similar articles
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098. Hum Reprod. 2004. PMID: 14688154 Review.
-
Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.Hum Reprod. 2024 May 2;39(5):1072-1077. doi: 10.1093/humrep/deae042. Hum Reprod. 2024. PMID: 38514450
-
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17. J Clin Endocrinol Metab. 2006. PMID: 16418211
-
Best methods for identification and treatment of PCOS.Minerva Ginecol. 2010 Feb;62(1):33-48. Minerva Ginecol. 2010. PMID: 20186113 Review.
-
Polycystic ovary syndrome in adolescents.Best Pract Res Clin Endocrinol Metab. 2019 Jun;33(3):101272. doi: 10.1016/j.beem.2019.04.006. Epub 2019 Apr 13. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31027973 Review.
Cited by
-
Association between fasting blood glucose and carotid intima-media thickness of polycystic ovary syndrome patients with normal glucose tolerance.Diabetes Care. 2013 May;36(5):e66-7. doi: 10.2337/dc12-1924. Diabetes Care. 2013. PMID: 23613607 Free PMC article. No abstract available.
-
DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study.Turk J Obstet Gynecol. 2021 Jun 2;18(2):124-130. doi: 10.4274/tjod.galenos.2021.39024. Turk J Obstet Gynecol. 2021. PMID: 34083652 Free PMC article.
-
DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS.BMC Med Genomics. 2021 May 9;14(1):125. doi: 10.1186/s12920-021-00962-7. BMC Med Genomics. 2021. PMID: 33964924 Free PMC article.
-
Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial.Ann Transl Med. 2021 Mar;9(5):387. doi: 10.21037/atm-20-1592. Ann Transl Med. 2021. PMID: 33842608 Free PMC article.
-
Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging.Front Endocrinol (Lausanne). 2023 Dec 13;14:1324429. doi: 10.3389/fendo.2023.1324429. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38192421 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical